Shares of health-care companies were flat as traders rotated into more economically sensitive areas in light of growth and interest-rate outlooks.
Johnson & Johnson's Animas Corp. unit is set to close and exit the insulin pump business, the company said, citing increased competition that made selling the pumps unsustainable.
Continue Reading Below
Rob Curran, email@example.com
(END) Dow Jones Newswires
October 05, 2017 17:17 ET (21:17 GMT)